What happens when I stop taking GLP-1s? Will I regain the weight?

Short answer: yes — many people regain at least some (often most) of the weight they lost after stopping a GLP‑1 drug. That happens because the medication’s appetite‑suppressing and metabolic effects stop, and your body’s biology pushes your weight back toward its previous set point.

What’s going on

• How GLP‑1s (for example, semaglutide brands Wegovy/Ozempic/Rybelsus, tirzepatide brands Mounjaro/Zepbound, or liraglutide brand Saxenda) work: they reduce appetite, slow gastric emptying, and change hunger/satiety signaling.
• When you stop, those effects reverse — appetite increases, gastric emptying speeds up, and energy expenditure can fall. Hormonal and neural “hunger” signals (and cravings) often return.
• Clinical trials and real‑world experience show substantial weight regain over months to a year for many people who discontinue the drugs unless other maintenance measures are in place. If you have type 2 diabetes, stopping can also worsen blood sugar control, so monitoring and alternative glucose medications may be needed.

What you can do to reduce weight regain

• Discuss a plan with your prescriber before stopping. Don’t stop abruptly without a medical plan, especially if you’re taking these drugs for diabetes or on other glucose‑lowering meds.
• Continue or intensify behavioral strategies that helped you lose weight: a calorie‑controlled eating plan, regular physical activity (including resistance training), structured self‑monitoring (weigh‑ins, food tracking), sleep and stress management. Programs/services that help: Noom (behavior change coaching), WW (Weight Watchers) for ongoing support, or working with a registered dietitian (find one through the Academy of Nutrition and Dietetics).
• Consider long‑term maintenance therapy: many clinicians treat obesity as a chronic condition and continue medication long term because the weight loss is sustained while the drug is continued. Discuss pros/cons and cost/insurance issues with your clinician.
• If GLP‑1s aren’t a long‑term option, ask about other medication alternatives (e.g., phentermine/topiramate, bupropion‑naltrexone, orlistat) or referral to an obesity specialist or an ABOM‑certified physician for a personalized plan. For some people, bariatric surgery (sleeve gastrectomy, Roux‑en‑Y gastric bypass) is a durable option — discuss eligibility with a bariatric surgeon.
• Consider structured maintenance programs or medical weight‑management clinics (look for Obesity Medicine Association clinics or local multidisciplinary programs) for ongoing support.

Practical next steps

1. Talk with the prescriber who started your GLP‑1: explain why you want to stop and make a plan (taper vs stop, monitoring for blood glucose, alternative therapies).
2. Arrange follow‑up: weight checks, A1c or glucose monitoring if diabetic, and behavioral support (dietitian, obesity clinic, or a program like Noom/WW).
3. If cost/side effects are the reason you want to stop, ask about dose adjustments, switching brands, or financial assistance programs offered by manufacturers.

If you want, tell me which GLP‑1 you’re taking and why you’re thinking of stopping (cost, side effects, pregnancy, finished goal, etc.), and I can suggest a more specific plan you can bring to your clinician.